Results 241 to 250 of about 214,611 (264)

A case of invasive lobular carcinoma with signet-ring-cell differentiation treated with multidisciplinary therapy: a rare case report. [PDF]

Front Oncol
Takuwa H, Hori T, Goda N, Takeuchi M.
europepmc   +1 more source

Breast Skin Lesions in a 79‐Year‐Old Woman

JEADV Clinical Practice, EarlyView.
Javier Lorenz‐Dolz, Fátima Mayo‐Martínez, Andrea Díez Santandreu, Onofre Sanmartín Jiménez, Ruggero Moro   +4 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Systemic therapy for hormone receptor-positive/human epidermal growth factor receptor 2-negative early stage and metastatic breast cancer

Ca-A Cancer Journal for Clinicians, 2023
Hope Rugo, Özge Gümüşay, Laura A Huppert   +2 more
exaly  

Co-occurring gain-of-function mutations in HER2 and HER3 modulate HER2/HER3 activation, oncogenesis, and HER2 inhibitor sensitivity

Cancer Cell, 2021
Benjamin P Brown, Kyung-Min Lee, Jens Meiler   +2 more
exaly  

HER2-low expression in patients with advanced or metastatic solid tumors

Annals of Oncology, 2023
C Haymaker, G Abbadessa, T A Yap
exaly  

Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond

Seminars in Cancer Biology, 2021
Laura Annaratone, Enrico Berrino, Laura Casorzo   +2 more
exaly  

Evolving standards of care and new challenges in the management of HER2-positive breast cancer

Ca-A Cancer Journal for Clinicians, 2020
Ciara C O'Sullivan, Grace D Cullen, Grace M Choong   +2 more
exaly  

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

Annals of Oncology, 2023
J S Reis-Filho, H J Burstein, A Bardia
exaly